Dr. John Payne, DO
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $169.18 | 12 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CSL Behring | $48.36 | 3 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $46.21 | 3 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $37.73 | 3 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $24.38 | 2 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $12.50 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $11.52 | 1 | Merck Sharp & Dohme Corporation ($11.52) |
| 2018 | $42.60 | 3 | CSL Behring ($17.14) |
| 2017 | $115.06 | 8 | AstraZeneca Pharmaceuticals LP ($46.21) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/23/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $11.52 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/17/2018 | CSL Behring | Berinert (Biological) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Immunology | ||||||
| 01/24/2018 | SANOFI-AVENTIS U.S. LLC | DIABETES - DISEASE (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| 01/16/2018 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: NEPHROLOGY | ||||||
| 12/08/2017 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Respiratory | ||||||
| 11/02/2017 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: NEPHROLOGY | ||||||
| 10/10/2017 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), ASMANEX, JANUMET XR | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: VACCINE | ||||||
| 10/03/2017 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Respiratory | ||||||
| 09/05/2017 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: Respiratory | ||||||
| 06/15/2017 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Critical Care | ||||||
| 05/09/2017 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), ASMANEX, JANUMET XR | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: VACCINE | ||||||
| 04/11/2017 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Critical Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 342 | 868 | $118,855 | $48,787 |
| 2022 | 16 | 372 | 562 | $92,104 | $38,577 |
| 2021 | 7 | 214 | 359 | $59,760 | $25,198 |
| 2020 | 13 | 339 | 525 | $88,305 | $38,571 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 89 | 119 | $26,180 | $10,203 | 39.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 51 | 155 | $19,547 | $9,530 | 48.8% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 13 | 238 | $19,888 | $7,130 | 35.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 38 | 42 | $9,576 | $4,277 | 44.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 31 | 31 | $8,866 | $3,921 | 44.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 14 | 104 | $10,650 | $3,758 | 35.3% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 12 | 79 | $9,047 | $3,015 | 33.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 43 | 46 | $5,868 | $2,844 | 48.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 27 | 27 | $4,185 | $1,793 | 42.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 14 | $2,632 | $1,212 | 46.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 13 | 13 | $2,416 | $1,103 | 45.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 85 | 124 | $27,280 | $10,189 | 37.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 55 | 114 | $13,908 | $6,337 | 45.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 25 | 25 | $7,495 | $3,227 | 43.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 23 | 39 | $6,825 | $3,110 | 45.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 17 | 17 | $5,739 | $2,629 | 45.8% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 15 | 15 | $4,610 | $2,092 | 45.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 19 | 19 | $4,356 | $1,997 | 45.8% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2022 | 13 | 63 | $5,103 | $1,873 | 36.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 25 | 27 | $3,294 | $1,513 | 45.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 22 | $3,410 | $1,352 | 39.6% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 11 | 11 | $2,497 | $1,132 | 45.4% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 13 | 23 | $2,530 | $974.74 | 38.5% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 14 | 27 | $2,700 | $955.62 | 35.4% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 12 | 12 | $1,464 | $667.70 | 45.6% |
About Dr. John Payne, DO
Dr. John Payne, DO is a Student in an Organized Health Care Education/Training Program healthcare provider based in Lubbock, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2013. The National Provider Identifier (NPI) number assigned to this provider is 1477991180.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Payne, DO has received a total of $169.18 in payments from pharmaceutical and medical device companies, with $11.52 received in 2019. These payments were reported across 12 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($169.18).
As a Medicare-enrolled provider, Payne has provided services to 1,267 Medicare beneficiaries, totaling 2,314 services with total Medicare billing of $151,134. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Internal Medicine
- Location Lubbock, TX
- Active Since 06/05/2013
- Last Updated 01/21/2022
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1477991180
Products in Payments
- BEVESPI AEROSPHERE (Drug) $46.21
- Kcentra (Biological) $31.22
- PNEUMOVAX 23 (Biological) $26.21
- SAMSCA (Drug) $24.38
- Berinert (Biological) $17.14
- DIABETES - DISEASE (Drug) $12.50
- ZERBAXA (Drug) $11.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Lubbock
Shiraz Yazdani, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $361,719
Dr. Amputch Karukote, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $20,032
Emadeldeen Elgwairi, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $15,231
Dr. Gabriel Axelrud, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $11,301
Ryan Owen, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $10,411
Dr. Bennett Henderson, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $9,878